Distributed Bio News Today

William Blair 43rd Annual Growth Stock Conference June 6, 2023 ... | June 6, 2023

Basel, Switzerland (PRWEB) February 08, 2022 -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced

Charles River says the combination of Distributed Bio’s platform, which the CRO recently acquired, with its own downstream characterization capabilities, enables identification of the best lead candidate in CAR T cell therapies – balancing efficacy and safety for optimal therapeutic outcome. Teams from Charles River and Distributed Bio presented research at AACR 2021 in April detailing how their technology and expertise benefits CAR T cell therapy developers. Di...

Welcome to Twist Bioscience Fiscal 2021 Second Quarter Financial Results Conference Call. [Operator Instructions] I would now like to turn the conference call over to Jim Thorburn, Chief Financial Officer. Jim Thorburn -- Chief Financial Officer Thank you, operator. Good afternoon, everyone. Id like to thank all of you for joining us today for Twist Bioscience conference call to review our fiscal 2021 second quarter financial results and business progress. We did issue our financial results ea...

Charles River Laboratories International Inc (CRL) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Charles River Laboratories International Inc (NYSE: CRL) Popular Searches Operator Good day, and thank you for standing by. Welcome to the Charles River Laboratories First Quarter 2021 Earnings Conference Call. [Operator Instructions] [Operator Instructions] I would now like to hand the conference over to your ...

Biotechnology Company Centivax Officially Launches News provided by Share this article Share this article SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Centivax Inc. is proud to announce its launch on Jan. 1, 2021, as a fully independent biotechnology company developing broad-spectrum therapeutics and a vaccines portfolio, including indications in COVID-19, multi-drug resistant bacteria, influenza, antivenom and oncology. "Our unusually mature portfolio of fully owned Centivax assets has been...

Charles River Acquires Cell and Gene Therapy CDMO Cognate for $875M Charles River Laboratories plans to acquire the cell and gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices for approximately $875 million cash, in a deal that further expands the buyer’s activity in the fast-growing sector. [Cognate BioServices] February 18, 2021 Charles River Laboratories plans to acquire the cell and gene therapy contract development and manufacturing organization ...

Charles River Laboratories International Inc (CRL) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Charles River Laboratories International Inc (NYSE: CRL) Popular Searches Operator Ladies and gentlemen, thank you for standing by and welcome to Charles River Laboratories International Fourth Quarter Earnings Conference Call and 2021 guidance call. At this time, all participants are in a listen-only mode [Ope...